Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Classic medulloblastoma is a histological variant of medulloblastoma, an embryonic malignancy, having a midline location, occurring most often in children and manifesting with variable symptoms such as headaches, nausea, vomiting and ataxia.
No clinical trials have been registered for classic medulloblastoma.
4 publications have been identified in PubMed for classic medulloblastoma. Research spans Basic Science / Preclinical (50%), Clinical Trial Publication (25%), and Epidemiology / Natural History (25%).
Zhang J (2025). [PMID: 40303994](https://pubmed.ncbi.nlm.nih.gov/40303994/). *Frontiers in oncology*. [Basic Science / Preclinical]
Zhang J (2025). [PMID: 40575173](https://pubmed.ncbi.nlm.nih.gov/40575173/). *Frontiers in oncology*. [Basic Science / Preclinical]
Nguyen P (2025). [PMID: 40336980](https://pubmed.ncbi.nlm.nih.gov/40336980/). *International journal of particle therapy*. [Clinical Trial Publication]
Sun M (2024). [PMID: 38914641](https://pubmed.ncbi.nlm.nih.gov/38914641/). *Scientific reports*. [Epidemiology / Natural History]
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 11:54 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about classic medulloblastoma